I think SLC is right. We'll never know the reason for Lang's departure. Hopefully it's because Lang's services will no longer be needed as we'll shortly be paired up with a more experienced BP pharma regulatory team.
(1)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.